#4 – How ECCMID 2019 went viral
Breakpoints10 Jul 2019

#4 – How ECCMID 2019 went viral

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review results of ASPECT-NP (Ceftolozane-tazobactam versus meropenem in patients with ventilated nosocomial pneumonia), CAMERA-2 (Combination therapy for methicillin-resistant Staphylococcus aureus bacteraemia), and Exebacase for patients with methicillin-resistant Staphylococcus aureus bacteraemia (Phase 2).

Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
rss-bisarr-historie
treningspodden
jakt-og-fiskepodden
rss-strid-de-norske-borgerkrigene
rss-kunsten-a-leve
mikkels-paskenotter
rss-sunn-okonomi
sinnsyn
hverdagspsyken
rss-kull
tomprat-med-gunnar-tjomlid
lederskap-nhhs-podkast-om-ledelse
fryktlos
gravid-uke-for-uke
hagespiren-podcast
rss-bak-luftfarten